P

Inventor

ZION TODD C

US50 patents
⚠️ This page may combine multiple inventors who share the name “ZION TODD C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AKSTON BIOSCIENCES CORP

22 patents
US10961294B2Mar 30, 2021

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP24 citations94
US10947292B2Mar 16, 2021

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP23 citations94
US10870686B2Dec 22, 2020

Ultra-long acting insulin-FC fusion proteins and methods of use

AKSTON BIOSCIENCES CORP23 citations94
US10851147B2Dec 1, 2020

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP23 citations94
US10597435B2Mar 24, 2020

Insulin-Fc fusions and methods of use

AKSTON BIOSCIENCES CORP21 citations92
US11261229B2Mar 1, 2022

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP3 citations84
US11192930B2Dec 7, 2021

Ultra-long acting insulin-Fc fusion protein and methods of use

AKSTON BIOSCIENCES CORP5 citations84
US11186623B2Nov 30, 2021

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP6 citations84
US11359001B2Jun 14, 2022

Insulin-Fc fusions and methods of use

AKSTON BIOSCIENCES CORP7 citations83
US11919935B2Mar 5, 2024

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP2 citations73
US11814418B2Nov 14, 2023

Ultra-long acting insulin-Fc fusion protein and methods of use

AKSTON BIOSCIENCES CORP2 citations73
US11773151B2Oct 3, 2023

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP2 citations73
US11673934B2Jun 13, 2023

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP2 citations73
US11267862B2Mar 8, 2022

Ultra-long acting insulin-Fc fusion proteins and methods of use

AKSTON BIOSCIENCES CORP3 citations73
US11198719B2Dec 14, 2021

Ultra-long acting insulin-Fc fusion protein and methods of use

AKSTON BIOSCIENCES CORP2 citations73
US11213581B2Jan 4, 2022

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

AKSTON BIOSCIENCES CORP3 citations71
US12454565B2Oct 28, 2025

PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use

AKSTON BIOSCIENCES CORP1 citations64
US12195511B2Jan 14, 2025

Ultra-long acting insulin-Fc fusion protein

AKSTON BIOSCIENCES CORP0 citations62
US11555058B2Jan 17, 2023

Cells engineered to express ultra-long acting insulin-Fc fusion proteins

AKSTON BIOSCIENCES CORP0 citations62
US11352407B2Jun 7, 2022

Ultra-long acting insulin-Fc fusion proteins

AKSTON BIOSCIENCES CORP1 citations62
US11707517B2Jul 25, 2023

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

AKSTON BIOSCIENCES CORP0 citations60
US11667689B2Jun 6, 2023

Insulin-Fc fusion proteins and methods of use to treat cancer

AKSTON BIOSCIENCES CORP0 citations52

SMARTCELLS INC

8 patents

ZION TODD C

7 patents

LANCASTER THOMAS M

4 patents

MASSACHUSETTS INST TECHNOLOGY

2 patents

EASTMAN KODAK CO

2 patents

NEXPRESS SOLUTIONS LLC

1 patent

CHEN ZHIYU

1 patent

YING JACKIE Y

1 patent

DECHRA LTD

1 patent

VAKSTON INC

1 patent